Elanco Animal Health Inc (ELAN)
13.46
+0.53
(+4.10%)
USD |
NYSE |
Apr 23, 16:00
13.46
0.00 (0.00%)
Pre-Market: 20:00
Elanco Animal Health Cash from Operations (TTM): 271.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 271.00M |
September 30, 2023 | 127.00M |
June 30, 2023 | 118.00M |
March 31, 2023 | 369.00M |
December 31, 2022 | 452.00M |
September 30, 2022 | 662.00M |
June 30, 2022 | 562.00M |
March 31, 2022 | 399.00M |
December 31, 2021 | 483.00M |
September 30, 2021 | 167.00M |
June 30, 2021 | -34.00M |
Date | Value |
---|---|
March 31, 2021 | -23.00M |
December 31, 2020 | -41.00M |
September 30, 2020 | 178.20M |
June 30, 2020 | 329.80M |
March 31, 2020 | 219.90M |
December 31, 2019 | 224.00M |
September 30, 2019 | 237.30M |
June 30, 2019 | 361.60M |
March 31, 2019 | 448.40M |
December 31, 2018 | 487.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-41.00M
Minimum
Dec 2020
662.00M
Maximum
Sep 2022
266.46M
Average
237.30M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
Merck & Co Inc | 13.01B |
Catalent Inc | 174.00M |
NanoString Technologies Inc | -114.98M |
Cytokinetics Inc | -414.33M |
Geron Corp | -167.74M |